title: Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor.
authors.affiliation: Leukaemia Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
authors.forename: C
authors.initials: C
authors.lastname: Tiley
authors.forename: R
authors.initials: R
authors.lastname: Powles
authors.forename: C P
authors.initials: CP
authors.lastname: Teo
authors.forename: J
authors.initials: J
authors.lastname: Treleaven
authors.forename: M
authors.initials: M
authors.lastname: Findlay
authors.forename: M
authors.initials: M
authors.lastname: Hewetson
mesh_terms: D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000209:etiology; D006086:Graft vs Host Disease / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods*; D008558:Melphalan / Q000627:therapeutic use; D051379:Mice; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation / Q000009:adverse effects
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D015375:Receptors, Interleukin-2; D003520:Cyclophosphamide; D008558:Melphalan